Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic.

Catherine E LaiArnold L PotoskyColleen McGuireTania LoboJaeil AhnBassem R HaddadErnest W RichardsPalka AnandKristen WrightRobert H ChristensonLisa BoyleAndre GoyMichael B Atkins

Published in: Journal of oncology (2022)

These data suggest that patients are not at higher risk for febrile SARS-CoV-2 infections or more transient immunity than HCWs. Furthermore, racial differences and lack of association with the extent of HCW contact with COVID-19 patients suggest that community rather than hospital virus exposure was a source of many infections.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
healthcare
newly diagnosed
ejection fraction
chronic kidney disease
risk factors
peritoneal dialysis
electronic health record
patient reported outcomes
brain injury
patient reported
deep learning